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Mechanisms that initiate and control the natural hypometabolic states of
mammals are poorly understood. The laboratory developed a model of deep
hypometabolism (DH) initiated by uptake of 5’-adenosine monophosphate (5’-AMP)
into erythrocytes. Mice enter DH when given a high dose of 5’-AMP and the body
cools readily. Influx of 5’-AMP appears to inhibit thermoregulatory control. In a 15°C
environment, mice injected with 5’-AMP (0.5 mg/gw) enter a Phase I response in
which oxygen consumption (VO2) drops rapidly to 1/3rd of euthermic levels. The
Phase I response appears independent of body temperature (Tb). This is followed
by gradual body temperature decline that correlates with VO2 decline, called Phase
II response. Within 90 minutes, mouse Tb approaches 15°C, and VO2 is 1/10th of
normal. Mice can remain several hours in this state, before gradually and safely
recovering. The DH state translates to other mammalian species. Our studies show
uptake and metabolism of 5’-AMP in erythrocytes causes biochemical changes that
initiate DH. Increased AMP shifts the adenylate equilibrium toward ADP formation,
consequently decreasing intracellular ATP. In turn, glycolysis slows, indicated by
increased glucose and decreased lactate. 2,3-bisphosphoglycerate levels rise,
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allosterically reducing oxygen affinity for hemoglobin, and deoxyhemoglobin rises.
Less oxygen transport to tissues likely triggers the DH model.
The major intracellular pathway for AMP catabolism is catalyzed by AMP
deaminase (AMPD). Multiple AMPD isozymes are expressed in various tissues, but
erythrocytes only have AMPD3. Mice lacking AMPD3 were created to study control
of the DH model, specifically in erythrocytes. Telemetric measurements
demonstrate lower Tb and difficulty maintaining Tb under moderate metabolic stress.
A more dramatic response to lower dose of 5’-AMP suggests AMPD activity in the
erythrocyte plays an important role in control of the DH model. Analysis of
adenylates in erythrocyte lysate shows 3-fold higher levels of ATP and ADP but
similar AMP levels to wild-type.
Taken together, results indicate alterations in energy status of erythrocytes
can induce a hypometabolic state. AMPD3 control of AMP catabolism is important
in controlling the DH model. Genetically reducing AMP catabolism in erythrocytes
causes a phenotype of lower Tb and compromised ability to maintain temperature
homeostasis.
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Chapter 1
Overview of natural hypometabolism and
therapeutic hypothermia
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Overview of natural methods of energy conservation
Mammals and birds have high metabolic rates and generate large amounts
of heat even while at rest, allowing them to maintain a constant core body
temperature (Tb) of about 37°C. They can maintain normal Tb (euthermia) despite
losing body heat to a cold environment, by increasing heat production. This trait
comes at high energy cost and allows mammals and birds to live in extreme
environments including below freezing temperatures (1).
Some mammals and birds can undergo hypometabolic periods that allow
energy conservation. Most mammals experience shallow oscillations in metabolic
rate by up to 20% during the 24 hour rhythm of rest and activity. There is a
corresponding fluctuation in Tb, ranging from 0.5 to 2°C. Birds experience more
pronounced oscillations in metabolic rate and Tb (1).
In addition to the 24 hourly rhythm, many mammals and birds can undergo
extended periods of hypometabolism and reduced Tb. Some mammals experience
a daily temporary decline in metabolic rate and Tb, called daily torpor, often in
response to changes in photoperiod, decreased food availability, and colder
ambient temperature (Ta) (2). In response to lack of water in warm environments,
reptiles and amphibians undergo aestivation, which is a hypometabolic state similar
to torpor but without the decrease in Tb (3). Aestivation is rare in mammals, the best
described is the fat-tailed dwarf lemur in the tropics (4). Some mammals
undergo a seasonal extended period of deep torpor bouts, called hibernation. In
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daily torpor, aestivation and hibernation, metabolic rate can be reduced to a fraction
of the basal rate (1).
Among the diverse species of mammals, many orders, including carnivora,
primates, and rodentia have members that either hibernate or undergo daily torpor.
A large range of sizes of mammals can enter such hypometabolic states, from
shrews to bears. Hibernation experts suggest that this means all mammals share a
widespread ability to enter a hypometabolic state (1).
During hibernation an animal’s metabolic rate and Tb decreases in torpor
bouts that can last for several weeks, with periodic arousals to euthermia lasting
about one day. Small hibernators such as bats, marmots and ground squirrels, can
undergo a dramatic decrease in Tb, reaching temperatures close to or below
freezing. The metabolic rate of these small hibernators decreases to approximately
2-5% of basal metabolic rate (5). However, a much larger hibernating mammal such
as the bear undergoes a less dramatic change in Tb and metabolic rate. For this
reason, investigators in the hibernation field debated whether bears are true
hibernators. Recently, continuous telemetry and metabolic rate monitoring
performed in black bears led to the conclusion that they do hibernate. Bear Tb
declines from 37°C to a low of 30°C, with an average temperature of 33°C.
Metabolic rate of bears decreases to between 53 – 65% of normal rate (5). Even
tropical primates can hibernate. The fat-tailed dwarf lemur of Madagascar lives on
fruits and arthropods in the dry deciduous forest of Kirindy. During the dry season
the animals hibernate or aestivate in tree holes in response to food and water
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shortage. The Tb of these animals can fluctuate widely, depending on the Ta, and
they remain hypometabolic even when the Ta is above 30°C (4).
The mechanisms that initiate hypometabolic states such as torpor,
aestivation and hibernation are poorly understood. Environmental conditions that
can trigger these states are short photoperiod, cold Ta (in torpor), warm Ta (in
aestivation), and less food and water availability. Animals such as deer mice and
hamsters enter torpor in response to short photoperiod, even with free access to
food and water. However, food shortage can induce torpor in these animals during
any season (6). For decades investigators have tried to determine the molecular
and biochemical conditions that cause animals to enter such hypometabolic states.
Investigators have identified a complex of four proteins called hibernationspecific protein complex (HPc) that is a candidate hormone for control of
hibernation. It is produced in the liver, enters the bloodstream, and its expression
and transport into the brain are regulated by endogenous circannual rhythms (7). In
chipmunks, levels of HPc begin to decline in blood, and begin a simultaneous
increase in cerebrospinal fluid, prior to onset of hibernation. Levels remain low in
blood and peak in cerebrospinal fluid during the hibernation phase. At the end of
hibernation, HPc levels rise in blood and decline in cerebrospinal fluid. The
circannual changes in HPc levels are independent of changes in body temperature,
which raised questions to its correlation with the animal’s metabolic state (8).
Interestingly, in European hamsters it was found that the circadian clock is
stalled during deep torpor. The mRNA levels of three of the genes involved in the
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transcriptional feedback loop that drives the circadian clock were compared in
euthermic and hibernating hamsters. In contrast to the normal oscillation of mRNA
levels of Per1, Per2, and Bmal1 in euthermic animals, the transcripts in the
hibernating animals remained at steady levels, showing that the circadian clock was
no longer oscillating (9). However, the circadian clock appears to regulate the timing
of torpor behavior. It was shown that ablation of the hypothalamic suprachiasmatic
nucleus, the structure of the brain that is the pacemaker for the circadian clock,
changes timing of hibernation in ground squirrels (10).
Energy utilization in natural hypometabolic states
Energy sources were studied in Djungarian hamsters in torpor. It was found
that during the beginning of a torpor bout the animals primarily used carbohydrates
for energy, but that as the torpor bout progressed there is a progression towards
lipid metabolism as their primary energy source. (11).
Control of body temperature by the hypothalamus
The preoptic area of the hypothalamus is thought to play a central role in
regulating Tb. When Tb decreases, the preoptic area sends a signal to the
vasomotor center in the medulla to trigger an autonomic response that decreases
the diameter of peripheral blood vessels. In turn, this reduces blood flow to the skin,
which reduces the rate of heat loss to the environment (12). However, if the
vasomotor center is inhibited, peripheral vasodilation occurs, and the increased
blood flow to the skin causes heat loss to the environment. When the blood flow
increases, the sweat glands are stimulated, and this increases evaporative heat
5

loss. In addition, respiration rate is increased, which also causes heat loss through
evaporation (12). All these changes that control the Tb are thought to be triggered
by the preoptic area of the hypothalamus.
Cold and warm-sensitive neurons exist in the hypothalamus. Mice overexpressing the uncoupling protein 2 in hypocretin neurons were found to have
elevated temperature in the hypothalamus. These mice displayed a phenotype of
lower Tb by 0.3 – 0.5°C compared to wild-type littermates (13).
Thermogenesis by uncoupling oxidative phosphorylation
Uncoupling proteins act to uncouple the oxidation (electron transport chain)
from the phosphorylation (generating ATP from ADP) in oxidative phosphorylation
(14). The classical uncoupling protein, UCP1, is located in the inner membrane of
mitochondria in brown adipose tissue. It uses oxygen to combust substrate, and
releases heat without producing ATP. This allows non-shivering thermogenesis
(14). Adult humans and most large adult mammals do not have much brown
adipose tissue, but it is found in many adult small mammals and in newborn
mammals (14, 15). Uncoupling of oxidative phosphorylation is known to generate
heat to maintain Tb in many hibernating mammals, mammals adapted to cold Ta,
and in newborn mammals (16). Other uncoupling proteins, UCP2 and UCP3 have
been identified in other tissues, but there is ongoing debate about their roles in
thermogenesis (15).
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Artificial induction of hypometabolism
While the initiation mechanism of hypometabolism seen in hibernation and
torpor is still unknown, glucose metabolism appears to play a role. Siberian
hamsters can be induced into torpor by injection of 2-deoxyglucose (2-DG), a
metabolic inhibitor (17). 2-DG is a non-metabolizable analog of glucose that inhibits
the first enzyme in the glycolytic pathway, hexokinase. The length of the torpor
bouts can be modulated with short photoperiods. These observations implicate the
cellular production of ATP to be important for torpor. However, injection of a
different metabolic inhibitor, β-mercaptoacetate, which inhibits fatty acid oxidation in
mitochondria, does not induce torpor in these animals (17). These observations
suggest that the glycolytic pathway appears to play a key role in the induction of
torpor. In contrast, fatty acid oxidation does not appear to play a role in the
induction.
Another substance used to induce a torpor state in animals is 3iodothyronamine, a naturally occurring metabolite of T4, which is the most active
form of thyroid hormone. When rodents were given a large dose of 3iodothyronamine, they entered a hypometabolic state and had lowered heart rate.
Research is ongoing to determine the mechanism, which has been shown to be
active without entry into the brain. G-protein coupled receptor signaling is believed
to be involved (18, 19).
Microinjection of adenosine into the anteroventral preoptic region of the brain
was shown to induce hypothermia and simultaneous hypoxia-induced
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hyperventilation in rats. This mechanism is believed to act through the A1 adenosine
receptor, because injection of an A1 receptor – specific antagonist attenuated these
effects (20).
A model of “suspended animation” was developed in non-hibernating
mammals that is induced by inhalation of H2S gas. In the H2S model, animals enter
a hypometabolic state and lose ability to thermoregulate (21, 22). The H2S gas
induction of hypometabolism is thought to be through its inhibition of cytochrome c
oxidase activity. However, H2S gas is known to be rapidly taken up by the red blood
cells and has been shown to dissociate oxygen from hemoglobin in the reaction
HbO2 + 2H2S = Hb + 2H2O + 2S (23).
Another method investigators have used to induce hypometabolism and
dramatically decrease Tb in non-hibernating mammals is exsanguination. In this
method, replacement of blood with a saline solution can successfully and reversibly
reduce Tb of dogs to near freezing (24).
Although mechanisms of hibernation and torpor in the wild are not fully
understood, protective benefits of lowered body temperature and metabolic rate are
observed. For example, animals in hibernation do not suffer the harmful effects of
ischemia despite dramatic decreases in blood flow to tissues (25).
Therapeutic Hypothermia in the Clinic
Clinicians employ these protective benefits by artificially reducing body
temperature and metabolic rate in medical trauma cases. Therapeutic hypothermia
attenuates further injury in patients who have suffered stroke or myocardial
8

infarction. It is also used during surgeries such as transplant, cardiac bypass, and
aortic repair to prevent ischemia-reperfusion injury, a common complication
following major surgery (26).
Although more doctors have begun using therapeutic hypothermia in the past
decade, the methods are still considered risky because the patient’s body naturally
fights the decrease in body temperature, requiring administration of paralytic and
sedative drugs. The drug effects make it difficult to properly assess and treat the
patient (27). This challenge has prompted researchers to look for safer methods of
inducing hypothermia.
The goal of this dissertation is to describe my research on our laboratory’s
model of 5’-AMP – induced deep hypometabolism. It will describe investigations to
determine the role of 5’-AMP in the model, the site of initiation, and an aspect of
metabolic control of the model. This body of work contributes to the understanding
of the mechanisms of the model, which has possible potential for therapeutic use in
humans.
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Chapter 2
Experimental Procedures

10

Creation of AMPD3 deficient mice
ES cells containing the vector to make the AMPD3 deficient mice were
purchased from Knockout Mouse Project (KOMP), University of California, Davis,
CA. The vector was designed using the strategy for “knockout-first” alleles
described by the Stewart lab (28). The vector used the “knockout-first” technology to
insert the cassette into intron 1 before the essential exon (exon 2) of AMPD3 locus
to create a missense mutation that would result in a non-functional mRNA transcript
(Figure 1). The ES cells were originally produced by Lexicon (now Lexicon
Pharmaceuticals, Inc.), The Woodlands, TX, and then sold to KOMP. The ES cells
(C57Bl/6 background) were sent to the Transgenic and Stem Cell Service Unit of
the Brown Institute of Molecular Medicine, Houston, TX, for microinjection and
generation of chimeras. Eight male chimeras (C57Bl/6 wild-type, Balbc AMPD3
knockout) were generated, and all were mated with C57Bl/6 wild-type females
purchased from Harlan Laboratories, Houston, TX. Of the 8 chimeras, 2 were able
to produce germline transmission to create AMPD3 +/- mice, which were then mated
to produce the AMPD3 +/+, +/- and -/- mice used in experiments.
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Figure 1: The targeting vector design for AMPD3 knockout
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ESCell Clone (C57Bl/ 6 background)
Targetingvector – conditional (frameshift)
5' homology arm
(4607 bp)

3' homology arm
(5954 bp)

Knock-in vector into exon 2
3’ homology arm is in exon 3 and exon 4
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Metabolic Chamber description and use
For metabolic chamber experiments, mice were housed in a climatecontrolled metabolic chamber designed for mouse studies, the Comprehensive Lab
Animal Monitoring System (CLAMS), Columbus Instruments, Columbus, OH. It has
16 cages inside a precisely controlled temperature unit (temperature range 2 50°C, +/- 1°C). Each animal is housed individually in an airtight cage, and O2 and
CO2 going in and out of the cage is measured by high speed gas sensors on an
Open Circuit Oxymax Calorimeter, (Columbus Instruments, Columbus, OH). The
airflow into and out of the cage is calibrated against a known gas mixture before
each experiment. To avoid contamination of the sampled air, the sample flows
through Drierite to capture moisture, and ammonia filters capture urea. Samples are
taken every minute, cage by cage, with one extra minute for calibration, so if all 16
cages are used, then air in each cage is sampled every 17 minutes. Receivers on
the sides of each cage can collect telemetry data, which is measured at the same
frequency as the gas sensing. In some of the experiments, animals were implanted
with telemetry chips (G2 E-mitter, Mini-Mitter Respironics, Bend, OR). The cages
allow free access to food and water. Food consumption can be measured by
crushing the mouse chow pellets. The food hopper is on a scale, and as food is
removed, the negative balance is recorded. Length and frequency of feeding bouts
are also recorded.
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Surgical Implantation of Telemetry Chips into Mice
Telemetry chips are sterilized via ethylene oxide gas. Animals are
anesthetized via isoflurane gas mask to surgical plane of anesthesia. One dose of
antibiotic (Baytril, 5 mg/kg, s.q.) is injected at the incision site. One dose of
analgesia (Buprenorphine, 0.1 mg/kg, s.q.) is injected. The ventral surface of the
abdomen is clipped free of hair, and the animal is secured to a heated surgical
surface with adhesive tape. The shaved area is disinfected with Betadine. One dose
of local analgesic (0.25% Marcaine, < 1 ml/kg) is injected at the incision site. A
midline abdominal skin incision of no more than 2 cm is made 1 cm below the
diaphragm. Then the abdomen is opened by making a 2 cm incision along the linea
alba of fascia where the abdominal muscles join the midline. The intestines and
colon are gently reflected and the e-mitter is positioned in the abdominal cavity
along the saggital plane, placed in front of the caudal arteries and veins but dorsal
to the digestive organs. Non-absorbable nylon suture is passed through the silastic
tubing in the outer wall of the e-mitter capsule. The capsule is sutured to the body
wall to reduce migration of the e-mitter inside the body, and provide a more
accurate temperature reading. Organs are replaced, intestines and colon are
examined for kinks, and then the abdominal opening is closed with 5-0 Vicryl
absorbable suture material using a continuous interlocking running stitch. Then the
skin is closed with nylon suture material using interrupted mattress stitches. Then
the animal is removed from anesthesia, and given pain relief as needed and
monitored for the recovery period. Animals are not used in experiments until two
weeks after the surgery and they show signs of full recovery.
15

AMP Deaminase Activity Assay
This protocol was adapted from a protocol of Dr. Richard Sabina, University
of Wisconsin Medical School (e-mail correspondence). AMPD activity is quantified
by measuring formation of IMP when protein sample is added to a reaction mixture
with saturated amount of substrate (AMP). 20 ug soluble protein is placed in a 1.5
ml tube and the following reaction mixture is added: 25 mM imidazole, pH 7.0,
containing 0.2 mg/ml bovine serum albumin (BSA), 150 mM potassium chloride.
The mixture is prewarmed in a 37°C water bath and then 20 mM 5’-AMP is added to
initiate the assay. Total volume of the reaction mixture is 100 ul. A 50 ul aliquot is
removed at 60 minutes, frozen at -80°C, and stored at -20°C. Samples are analyzed
by high performance liquid chromatography (HPLC) (Alliance 2695 Separations
Module with 2998 Photodiode Array Detector, Waters, Millipore Corp.) using a 5 um
C18 reversed phase column (Custom LC, Inc., Houston, TX) and running a gradient
of mobile phase 20 mM ammonium phosphate, pH 5.1 with methanol added into the
gradient. The gradient is designed as 0-4 minutes 0% methanol, 4-6 minutes 0-8%
methanol, 6-8 minutes 8-20% methanol, 8-18 minutes 20% methanol.
Analysis of adenine nucleotides in erythrocyte lysate
Erythrocytes are isolated from whole blood by removing serum and washing
3 times in ice-cold phosphate-buffered saline. Cells are lysed by freeze/thaw and
then extracts are made by adding 3 volumes of ice-cold 70% methanol overnight.
The supernatant is removed after centrifugation at 12,000 x g at 4°C for 10 minutes.
Supernatant is evaporated to dryness and then resuspended in 200 ul mobile
phase. The pellet is used to determine protein concentration. Nucleotides in the
16

extracts are separated by HPLC (Alliance 2695 Separations Module with 2998
Photodiode Array Detector, Waters, Millipore Corp.) using a 5 um C18 reversed
phase column (Sunfire, Waters, Millipore Corp.) and running a gradient with mobile
phase of 150 mM KH2PO4 and 150 mM KCl, pH 6.0, with superimposed 15%
acetonitrile (ACN). The gradient is programmed as 0-20 sec 0% ACN, 20 s – 21 min
0-1.35% ACN, 24 min – 28 min 1.35-15% ACN, 29 min – 35 min 0% ACN.
Nucleotides are quantified against standard curves of purchased standards (SigmaAldrich, St. Louis, MO).
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Chapter 3
Introduction to the 5’-AMP - Induced Model of
Deep Hypometabolism
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Introduction
The 5’-AMP – induced deep hypometabolism model was a fortuitous
discovery in the laboratory, which primarily focuses on circadian rhythm research. A
microarray comparing gene expression in liver samples of wild-type mice kept in
12h:12h light/dark cycle or constant darkness found procolipase to be highly
expressed during constant darkness (29). Procolipase is a coenzyme for pancreatic
triglyceride lipase, and pancreatic lipase related proteins 1 and 2. These proteins
catabolize dietary fats into fatty acids and are only expressed in pancreas and
gastrointestinal tract, not in liver (30-32). Northern blot analysis of liver mRNA found
strong circadian pattern to the procolipase expression in wild-type mice during
constant darkness, but not during light-dark cycle. Wild-type mouse tissues
expressed procolipase only in stomach and pancreas in normal light/dark cycle, but
constant darkness caused expression in many other tissues (29).
Through a series of several experiments tracking the procolipase expression,
the observations suggested that procolipase expression is regulated by unknown
circulatory factor(s) that control expression during either light/dark cycle or constant
darkness. One of the approaches to identify the putative factor included high
performance liquid chromatography (HPLC) analysis of blood extracts from mice at
various time points in either light/dark cycle or constant darkness. From these
studies, it was observed that one of the four reproducible peaks in all the samples
had a strong circadian pattern in both the light/dark cycle and in constant darkness.
In addition, it was observed that the peak area in samples from constant darkness
was elevated compared to light/dark cycle, a feature consistent with the putative
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factor. The peak had a maximum absorbance at 260 nm, which suggested it may be
a nucleotide. The peak was confirmed to be 5’-AMP (29).
Synthetic 5’-AMP was injected into mice kept in light/dark cycle to test
whether it could induce expression of procolipase. Northern blot and RT-PCR
analysis demonstrated induced expression of procolipase in all peripheral tissues
sampled except for brain. Incidentally, the injection of 5’-AMP was found to induce a
transient state of torpor in mice and was observed to decrease core body
temperature (Tb) from 37°C to 26°C. (29).
Injection of 5’-AMP induces a deep hypometabolic state which is moderated
by ambient temperature
Further studies showed that mice can enter a reversible deep hypometabolic
state (DH) that can last several hours after treatment with 5’-AMP. Initial
investigations were performed to determine the physical parameters of the DH
state. A temperature-controlled Comprehensive Lab Animal Monitoring System
(CLAMS) metabolic chamber was used in our studies to measure the physiological
effects of the 5’-AMP injection on mice. Mice are housed in individual sealed cages
with free access to food and water. Air in the cages is sampled to calculate the
oxygen consumption, or VO2 in units of ml/kg/hr. Tb was measured simultaneously
by implanting telemetry chips into the animals (33).
We observed that placing the mice in a cold environment after 5’-AMP
injection caused more reduction in Tb compared to Tb of mice in a 23°C
environment. The effect of ambient temperature (Ta) on the reduction of Tb of mice
20

was investigated. The VO2 and Tb were monitored in mice injected with 0.5 mg/gw
5’-AMP and placed in either a 23°C or 15°C metabolic chamber (Figure 2 a,b).
Saline injected mice were used as controls. The saline-injected mice, at both 23°C
or 15°C, maintained normal VO2 levels in the range of 4000 to 6500 ml/kg/h. In
addition, they maintained Tb of approximately 37°C regardless of Ta. In contrast,
between sampling points (~8 minutes) mice given 5’-AMP displayed a very steep
and rapid decrease in VO2, to below 2000 ml/kg/h, and this occurred in both the
23°C and the 15°C Ta groups. The first decrease in VO2 is referred to as the Phase
I response. However, both Ta groups given 5’-AMP experienced only a small drop in
Tb during the Phase I response. The saline injected animals in both groups did not
experience a Phase I response, and they maintained euthermic Tb throughout the
experiment.
After the Phase I response, the effects of the two Tas diverged in the 5’-AMP
injected groups. The decline in VO2 corresponded with a decrease in Tb. This was
classified as the Phase II response, where the decline in Tb corresponds to the
further decline in VO2.
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Figure 2: Relationship between VO2, Tb and Ta following 5’-AMP injection. a and b,
simultaneous measurement of Tb and VO2 of mice given saline or 5’-AMP (0.5
mg/gw, indicated by arrow) in individual metabolic chambers at Ta of 23 and 15°C.
Each mouse used in the study is represented by the same color trace for VO2 and
Tb. Sampling time for both Tb and VO2 was about 8 min. The colors reflect VO2 and
Tb of independent measurement of different animals given either saline or 5’-AMP.
c, respiration rate of mice (n=4) with Tb ~16°C compared with 37°C. d, heart rate of
mice (n=3) with Tb 16°C compared with 37°C. *, p<0.001, paired t test. Error bars,
S.E.M. This research was originally published in The Journal of Biological
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR,
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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The VO2 of mice in the 23°C environment reached a lowest point at
approximately 1000 ml/kg/h, and their Tbs decreased to approximately 26 – 28°C. In
contrast, the mice in the 15°C environment had a more dramatic decrease in VO2
and Tb, to approximately 300 ml/kg/h and 16°C, respectively. These data show that
colder Ta facilitates greater loss of body heat to the environment, allowing the mice
in 15°C to reach a lower Tb and attain a much lower VO2.
The breathing rate and heart rate of mice before and after 5’-AMP injection
was also measured. Mice had a normal breathing rate of approximately 120 breaths
per minute. After injection of 0.5 mg/gw 5’-AMP, and cooling to a Tb of 16°C, the
breathing rate decreased to approximately 10 breaths per minute. There was a
similarly dramatic decrease in heart rate, from approximately 600 beats per minute
to 50 beats per minute (Figure 2 c,d). These physical measurements indicate that
the mice were in an extremely low metabolic state and we regarded them to be in
deep hypometabolism (DH).
In summary, the Phase I response is rapid, occurring soon after injection of
5’-AMP, and it is independent of Tb decrease. In contrast, the Phase II VO2
response is more gradual, and apparently depends on the animal’s Tb, which in turn
is regulated by Ta. Marked reductions in breathing rate and heart rate accompany
the entry into DH.
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Observations and description of mice in DH
Distinct physical responses were observed in mice when they enter different
degrees of hypometabolism. When the Tb reaches approximately 17°C, they are
unable to right themselves when placed on their backs. However, they will respond
to stimuli such as touch, but appear to be in a deep stupor. The mice do sometimes
scratch, urinate, and roll side to side on their backs when in this state. Based on
observations of the animals’ behavior, it was determined that mice enter the DH
state when Tb reaches 17°C or below. The Tb generally stays one or two degrees
above the Ta during the DH state. In our studies, the mice are maintained in the DH
state at Ta of 15°C and a Tb of about 16°C. When Tb falls below 14°C, it can be fatal
within a few hours.
We observed that mice kept in a 15°C Ta will arouse spontaneously from the
DH state. VO2 and Tb will both rise slowly at first. However, when the Tb reaches
approximately 22°C, the mice will start shivering and the VO2 will rise rapidly. Within
two hours their Tb will have returned to euthermia and normal behaviors such as
grooming, eating and drinking and social behaviors are apparent. There was no
difference in cognitive function of the mice after DH, as evaluated for both long-term
and short-term effects by Morris Water maze testing (Figure 3). The animals
showed no difference in escape latency. Also, there was no observed difference in
lifespan of mice having undergone DH (33). The DH model works equally in male
and female mice.
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Figure 3: Morris Water Maze escape latency of mice before and after DH. n = 20,
mice used were 8 weeks old and were trained to escaping from water maze for 6
days before the experiment. The experiment was repeated 3 times and results are
presented as +/- S.E.M. No significant difference between DH and before DH.
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The dose of 5’-AMP induces the DH state but does not control its length
As shown in Figure 2b, the length of time in DH of individual mice is variable,
generally lasting from 2-8 hours. The variability of length of time in DH caused us to
question whether a larger dose of 5’-AMP could prolong the effect. To investigate
the effect of different dosages of 5’-AMP on the length of time in DH, groups of mice
with telemetry implants were injected with saline or a dose of 5’-AMP from 0.1
mg/gw to 1 mg/gw and placed in a 15°C CLAMS metabolic chamber (Figure 4
a,b,c,d).
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Figure 4: DH as a function of 5’-AMP dosage. a-d, simultaneous measurement of
Tb and VO2 of mice given different dosages of 5’-AMP and maintained at Ta of 15°C.
The different colors in the graph reflect VO2 and Tb of different animals used in the
study. This research was originally published in The Journal of Biological Chemistry.
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC.
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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Mice given saline maintained approximately 37°C Tb under these conditions.
The VO2 had normal fluctuations between 3500 – 4500 ml/kg/h, coinciding with
periods of rest and activity. Both mice given 0.1 mg/gw 5’-AMP experienced the
Phase I response, and a rapid decrease in VO2 from 4000 to 1500 ml/kg/h between
the sampling points following 5’-AMP administration. One of the animals had a short
Phase II response that corresponded with a slight decrease in Tb, but it did not enter
DH. The other animal had an aborted Phase II response, and its Tb decreased a
few degrees before returning to euthermia. In contrast, mice given 0.25 mg/gw 5’AMP both experienced the Phase I and Phase II responses, and stayed in DH
several hours. Finally, mice given the highest dose, 1.0 mg/gw 5’-AMP, had Phase I
and Phase II responses and stayed in DH for similar length as lower doses.
These studies revealed that the Phase I response was similar in all the 5’AMP treated mice, from the lowest to the highest dosages and is independent of Tb.
For most mice to enter DH under the experimental condition used, a minimum dose
of 0.25 mg/gw was required. Thus, our studies revealed that once the minimum
dose of 5’-AMP is reached, giving a higher dose does not extend the time in DH.
Therefore, it was concluded that the 5’-AMP injection of 0.25 mg/gw or more
initiates DH, but does not control the length of time in that state. However, as shown
previously in Figures 2a and 2b, for mice given the same dose of 5’-AMP, the Ta
plays an important role in the length of time in DH. Of the mice given 0.5 mg/gw 5’AMP, the group in the 15°C environment stayed in the state for lengths ranging from
2 to 8 hours, whereas the group in the 23°C environment only lasted less than 2
hours.
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Higher Ta causes more rapid recovery from DH
The studies above showed that Ta is important in allowing the animal to cool,
but it was important to test the effect of Ta on how quickly animals recover from DH.
Mice were injected with 0.5 mg/gw 5’-AMP and placed in the 15°C metabolic
chamber until their Tb reached about 16°C. Then, each group was placed in a
different Ta, and the Tb was monitored until the animals had fully recovered to
euthermia (Figure 5).
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Figure 5: Arousal from DH and the rise in Tb of mice maintained at various Ta
values. (n=4) This research was originally published in The Journal of Biological
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR,
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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Mice kept in 15°C Ta stayed in DH the longest. As the Ta increased, the
recovery from DH was correspondingly faster. These data demonstrate that the Ta
is important in modulating the length of time it takes for arousal. However, the fact
that once the minimum dose of 5’-AMP is reached, the dose of the 5’-AMP does not
extend the length of time in DH, and the variability of length in DH, shows there are
still factors that control arousal that remain unknown. This is supported by
observations that giving the animals a second injection of 5’-AMP failed to prolong
DH, and instead it led to increased mortality. In addition, further reduction of Tb to
14°C or lower led to increased mortality.
In summary, the Phase I response of a rapid and dramatic decline in VO2
after 5’-AMP injection does not depend on the Ta or the Tb of the animals. However,
the Phase II response, which is a more gradual decline in VO2, accompanied by a
parallel decline in Tb, is controlled by the Ta. During Phase II the Ta mediates the
extent to which the animal will cool, as the body heat is transferred from a warm to a
cooler state. However, the length of time until arousal varies for animals that have
already entered DH and are maintained at the same Ta. Increased Ta enhanced the
arousal and recovery rate from DH.
Other species have successfully been induced into DH.
It was important to determine whether the effect of 5’-AMP would translate to
larger mammals because it could possibly be used for therapeutic purposes in
humans in the future. Also, it is easier to make some physiological measurements in
larger mammals.
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Induction of a rat into DH
To test whether the effect of 5’-AMP will work in larger rodents, large male
Sprague-Dawley rats, weighing 450 – 550g, were injected with 0.5 mg/gw 5’-AMP
i.p., and cooled initially at 4°C Ta. After approximately 2 hours, the animals entered
DH when the animal’s ability to right itself when laid on its side was no longer
possible, with a corresponding Tb of 18 - 20°C. Transferred to 15°C Ta, the rats
were able to maintain DH for 6 hours, after which they were gradually rewarmed to
euthermia (Figure 6a). Thus, my studies showed that another species of rodent
displayed a similar response to 5’-AMP – induced deep hypometabolism.
Induction of a dog into DH
To determine if the DH model works in another species of mammals, a
beagle mix dog, weighing approximately 5 kg, was given 1.5 mg/g 5’-AMP via i.p.
injection, and placed initially in a 4°C environment (Figure 6b). After 3 hours the
animal entered the DH state, with a Tb of 22°C. It was transferred to an 18°C
environment and it maintained a Tb of 21-22°C for 8 hours, after which it was
gradually rewarmed to initiate arousal. After about 8 more hours it had returned to
euthermia. These findings demonstrated that a larger species, the dog, is able to
enter 5’-AMP – induced deep hypometabolism.
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Figure 6: Rat and dog induced into DH by injection with 5’-AMP and cooling. a, A
representative profile of a 450 g male Sprague-Dawley rat was injected i.p. with 0.5
mg/gw 5’-AMP and cooled in a 4°C Ta for 2 hours until the animal had entered DH
with a Tb of ~18°C. Then it was maintained in 15°C Ta with a Tb of 18-20°C for 6
hours, and then gradually rewarmed to induce arousal. b, A representative profile of
a ~5 kg beagle mixed breed dog injected i.p. with 1.5 mg/gw 5’-AMP and cooled in
a 4°C Ta for 3 hours until the animal had entered DH with a Tb of ~22°C. Then it was
transferred to 18°C Ta and its Tb remained at ~21-22°C for 8 hours, then the animal
was gradually rewarmed to induce arousal, and it returned to euthermia within 8
hours. This research was originally published in The Journal of Biological
Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR,
Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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Induction of a pig into DH
The effect of 5’-AMP – induced hypometabolism was also tested in pigs
because the pig physiology is similar enough to that of humans to be valuable
models for preclinical testing of drugs and surgical methods (34). A female Yucatan
micro-mini pig weighing 27 kg was injected with 1.0 g/kg 5’-AMP, i.v., through a
catheter inserted in the ear, and cooled with 10°C cooling blankets (Figure 7). The
animal was maintained on 2% inhaled isoflurane anesthesia for approximately 20
minutes before 5’-AMP injection, and then 1% isoflurane throughout the cooling
process. Tb was measured by esophageal probe. The animal began to slightly
shiver 100 minutes after injection, at which point Tb was 31°C. Anesthesia and
cooling were stopped, but Tb continued to decrease despite the shivering, reaching
a nadir of 29.6°C. Gradually the animal’s Tb rose and it returned to euthermia and
normal behaviors after several hours. While the pig was able to be cooled after
injection of 5’-AMP, anesthesia had to be used according to the institution animal
welfare guidelines, so it was not possible to separate the effects of the anesthesia
from the effects of the 5’-AMP.
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Figure 7: Induction of a pig into DH. A 27 kg Yucatan micro-mini pig was
administered 5’-AMP (1.0 mg/gw) intravenously over a 20 minute period (injection
time indicated in blue shading) under 2% isoflurane anesthesia and placed between
10°C cooling blankets. Cooling blankets and anesthesia were removed at 100 min
at onset of shivering but Tb continued to decline to a nadir of 29.6°C.
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In summary, 5’-AMP injection induces a hypometabolic state that is
moderated by Ta. There are two distinct phases of response after injection: a
Phase I response characterized by a rapid, dramatic decrease in VO2 with not much
decrease in Tb, and a Phase II response characterized by a gradual decline in VO2
and Tb that is dependent on the Ta. Once the minimum dose is reached, the dose
effect of 5’-AMP on length of time in DH and reduction of VO2 and Tb is not linear. In
addition to mice, rats, a dog, and pigs were induced into DH state by 5’-AMP
injection and cooling, and these data serve as proof of principle that the model
works in larger mammalian species. Therefore, the mechanisms for inducing the DH
state are shared in other species. Also, it suggests the model could potentially
translate to humans for clinical applications such as therapeutic hypothermia.
Understanding the fate of the injected 5’-AMP and the mechanisms that initiate the
DH state is important for future applications.
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Chapter 4
Investigation of the role of 5’-AMP in the
model of deep hypometabolism
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Since 5’-AMP can be converted to other molecules outside the cell, it was
important to determine whether 5’-AMP itself was initiating the model. As shown in
Figure 8, 5’-AMP can be converted to adenosine outside the cell in a reaction
catalyzed by 5’-ectonucleotidase, also called CD73 (14, 16). In addition, it is wellknown that 5’-AMP can be phosphorylated to form ADP and ATP via adenylate
kinase. The generation of 5’-AMP can come from catabolism of 3’,5’-cyclic
adenosine monophosphate (cAMP) by phosphodiesterase (14, 16).
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Figure 8: Adenosine metabolism and receptor signaling outside and inside the cell
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Can different nucleotides initiate the DH model?
Other mononucleotides were tested to investigate whether the hypometabolic
effects were specific to 5’-AMP. Mice were injected with 0.5 mg/gw of either 5’-AMP,
5’-cytidine monophosphate (5’-CMP), or 5’-guanosine monophosphate (5’-GMP)
and placed in the metabolic chamber at 15°C (Figure 9). The mouse given 5’-AMP
experienced the Phase I and Phase II responses, and remained in DH for almost 10
hours. In contrast, neither the 5’-CMP nor the 5’-GMP injected animals had any
significant change in VO2, and their Tb remained euthermic.
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Figure 9: Comparison of VO2 levels in mice given 5’-AMP, 5’-CMP, or 5’-GMP.
Each mouse was injected with 0.5 mg/gw of either nucleotide. This research was
originally published in The Journal of Biological Chemistry. Daniels IS, Zhang J,
O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem.
2010; 285:20716-20723. © the American Society for Biochemistry and Molecular
Biology.
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To test the effect of the other adenine nucleotides, mice were given 0.5
mg/gw ATP or cAMP, and response was compared to 5’-AMP injection. The
animals did have a response, but it took much longer for the drug to take effect
compared to the mice given 5’-AMP (Figures 10,11). The ATP-injected mouse
Phase I response was slower than in the 5’-AMP-injected animal. The VO2 of the
ATP-injected animal took longer to decline (Figure 10). Likewise, the cAMP-injected
mouse had a kinetic rate similar to ATP in its Phase I response which is much
slower than that displayed by 5’-AMP (Figure 11). The VO2 of the cAMP-injected
animal also took longer to decline. In addition, other investigators have found that
injection of 0.4 mg/gw ADP and ATP had similar effect to what we found with ATP
and cAMP (35). These results suggest that conversion of cAMP, ADP and ATP to
5’-AMP is required to have an effect.
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Figure 10: Injection of 5’-ATP results in slower Phase I response than 5’-AMP. VO2
and Tb were measured simultaneously in mice given 0.5 mg/gw 5’-AMP or 5’-ATP in
individual cages in metabolic chamber at 15°C. Red arrow indicates injection time.
a, VO2 b, Tb c, high resolution plot of VO2 from part a. Note the difference in Phase
I response. Time between sampling points is 3 min.
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Figure 11: Injection of cAMP results in slower Phase I response than 5’-AMP
a, VO2 was measured in mice treated with 5’-AMP or 3’,5’-cyclic AMP (cAMP), (0.5
mg/gw). The cAMP treated mouse displays slower Phase I response 5’-AMP
treated mouse. The cAMP treated mouse has an aborted Phase II response. The
boxed area is shown in higher resolution in b, with 5 min sampling time. This
research was originally published in The Journal of Biological Chemistry. Daniels IS,
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and
Molecular Biology.
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Adenosine was also tested. Mice given adenosine experienced a Phase I
response, with the quick decrease in VO2, but did not have a Phase II response,
and therefore did not enter DH (Figure 12). This transient effect of adenosine is not
surprising as its half-life is less than 10 seconds in the serum (36). The result
suggests adenosine is quickly metabolized before it can be phosphorylated into
enough 5’-AMP to cause a Phase II response.
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Figure 12: Injection of adenosine results in a Phase I response but an aborted
Phase II response. VO2 was measured in mice treated with saline, 5’-AMP (0.5
mg/gw) or adenosine (0.5 ml of 10 mg/ml) in 15°C Ta. This research was originally
published in The Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG,
Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:2071620723. © the American Society for Biochemistry and Molecular Biology.
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Loss of CD73 did not block 5’-AMP induction of DH
The enzymes and receptors involved in adenylate metabolism and signaling
are well studied, so they are useful tools in dissecting the fate of the injected 5’AMP. Outside the cell, 5’-AMP is dephosphorylated by the cell membrane anchored
enzyme 5’-ectonucleotidase/CD73 to form adenosine (Figure 8). Thus, if conversion
of 5’-AMP to adenosine outside the cell is required to initiate DH, then CD73
deficient mice would be highly resistant to DH induced by 5’-AMP. The metabolic
responses were compared between wild-type and CD73 deficient mice given 5’AMP and cooled. If conversion of 5’-AMP to adenosine outside the cell is essential
to initiate DH, then the CD73 deficient mice would be more resistant to 5’-AMP
induction of DH. The mice were injected with 0.5 mg/gw 5’-AMP and placed in a
15°C metabolic chamber (Figure 13a). Interestingly, the CD73 deficient mice
showed a similar response to the wild-type mice, with Phase I and Phase II
responses, and stayed in DH for several hours. This result suggests that the
dephosphorylation of 5’-AMP to adenosine by CD73 is not necessary to induce the
DH state.
Another experiment was performed to determine if the CD73 deficient mice
would respond differently to a lower dose of 5’-AMP (Figure 13b). Mice lacking the
enzyme CD73 would effectively be receiving a higher dose of 5’-AMP than the wildtype mice because the 5’-AMP is not being converted to adenosine. The dose of 5’AMP, 0.125 mg/gw, was chosen since it is not completely effective in initiating DH in
wild-type mice. Mice of each group (n = 12) were injected, and placed in a 4°C Ta
for one hour, and then Tb was measured rectally. Although a few of the wild-type
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mice did cool, the majority did not reach DH. In contrast, the majority of the CD73
deficient mice entered DH. The results from this experiment demonstrate that lack
of the CD73 enzyme makes a lower dose of 5’-AMP more effective.
Loss of adenosine receptors did not block 5’-AMP induction of DH
As part of analyzing the role of 5’-AMP conversion to adenosine outside the
cell, it was important to determine whether adenosine receptor signaling is
necessary to induce DH. Adenosine receptors have been shown to be involved in
thermoregulation (37). The reaction of wild-type mice to injection of saline or 5’-AMP
was compared to mice lacking either A1, A2A, A2B or A3 adenosine receptor (Figure
13c). Mice were given saline or 0.5 mg/gw 5’-AMP and then placed in a 4°C Ta for
one hour.
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Figure 13: Loss of adenosine receptors or 5’-ectonucleotidase deficiency does not
block DH induced by 5’-AMP injection. a, the VO2 profiles of
ectonucleotidase/CD73-deficient (n=2) and wild-type mice following 5’-AMP (0.5
mg/gw) administration. b, individual Tb of ectonucleotidase/CD73-deficient and wildtype mice (n=12) after 1h at 4°C Ta with injection of 0.125 mg/gw 5’-AMP. C, top, Tb
time course of mice, (n=4) with the adenosine receptor genotype A1-/-, A2A-/-, A2B-/-,
or A3-/- or wild-type were given 0.5 mg/g 5’-AMP after 1 h at 4°C Ta. bottom, Tb of
mice of the same genotype given saline after 1 h at 4°C Ta. Error bars, S.E.M. This
research was originally published in The Journal of Biological Chemistry. Daniels IS,
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and
Molecular Biology.
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Body temperature was measured rectally before injection, at 30 minutes and
at one hour. All the wild-type and adenosine receptor deficient mice reacted
similarly. The animals maintained body temperature after injection with saline. In
contrast, the 5’-AMP injected animals all cooled to a body temperature of about
17°C, and had entered DH by one hour post injection. The rate of cooling was
similar between all groups. Additionally, the VO2 response of the adenosine
receptor deficient mice was measured in the metabolic chamber (Figure 14). Wildtype and adenosine receptor deficient mice were placed in the metabolic chamber
at 15°C and treated with 0.5 mg/gw 5’-AMP. All the adenosine receptor deficient
mice behaved similarly to the wild-type mice. There was a rapid decline in VO2 for
the Phase I response, and then a slower decline in VO2 until the animals reached
DH. They remained in that state for several hours before arousal and recovery to
euthermia and normal VO2. These results demonstrate that no single adenosine
receptor is required to initiate the effect. This is important because it suggests that
adenosine signaling is not required for inducing the effect.
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Figure 14: Wild-Type and adenosine receptor deficient mice have similar metabolic
rate response to 5’-AMP injection and cooling at 15°C. Each line represents the VO2
profile of one adenosine receptor genotype A1-/-, A2A-/-, A2B-/-, or A3-/- or wild-type
mouse. Arrow indicates time of injection with 5’-AMP (0.5 mg/gw). Phase 1 (PI) and
Phase II (PII) responses are indicated.
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Rapid decrease in heart rate is not required to initiate DH
One of the striking physiological changes observed in animals injected with
5’-AMP is a rapid and dramatic decrease in heart rate. The A1 adenosine receptor is
known to mediate heart rate and vasodilation (37). Stimulating the A1 adenosine
receptor decreases heart rate by decreasing conduction of electrical impulses and
suppressing pacemaker cell function (38).
To determine whether adenosine receptor control of heart rate plays a role in
inducing DH, wild-type mice and mice deficient in A1, A2A, A2B or A3 adenosine
receptor were injected with 5’-AMP, placed in a 22°C environment, and heart rate
and Tb were monitored under isoflurane anesthesia for one hour (Figure 15). All the
mice cooled similarly, reaching a body temperature of approximately 23°C. The
heart rate of the wild-type and the A2A, A2B and A3 receptor deficient mice
decreased rapidly, reaching approximately 200 beats per minute within 2 minutes of
injection. In contrast, the heart rate of the A1 receptor deficient mice did not show
this rapid decrease. This result corresponds to the function of the A1 adenosine
receptor in mediating heart rate. Even though the A1 receptor deficient mouse did
not have the sharp decrease in heart rate after the 5’-AMP injection, it still cooled
similarly to the wild-type mouse and the other adenosine receptor deficient mice.
This shows that the adenosine receptor signaling influence on heart rate is not
required to induce the model, and also that the rapid decrease in heart rate itself is
an effect, and not a cause.
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Figure 15: Rapid decrease in heart rate is not essential to induce DH. One each of
wild-type, A1, A2A, A2B, and A3 adenosine receptor deficient mice were injected
with 0.5 mg/gw 5’-AMP at 22°C Ta. Heart rate and Tb were measured
simultaneously. Data from Dr. Zhenyin Tao, unpublished observation.
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In summary, the results from the CD73 deficient mice experiments show that
dephosphorylation of 5’-AMP to adenosine outside the cell is not required for the
initiation of DH. The loss of adenosine receptors did not affect the ability of 5’-AMP
to initiate the hypometabolic response. Adenosine can initiate the Phase I response
but its effect is rather short lived. The loss of A1 adenosine receptor did not block 5’AMP - induced DH but it blocked the rapid bradycardia effects of adenosine. The
kinetics of ATP and cAMP are much slower than that initiated by 5’-AMP in the
induction of DH. Other nucleotides including 5’-CMP and 5’-GMP are not effective.
The results suggested that 5’-AMP itself may be initiating the DH model. To gain
more insight into the mechanisms involved, we measured metabolic and
biochemical parameters.
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Chapter 5
The erythrocyte is the site of initiation for the
5’-AMP – induced model of deep
hypometabolism
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The results from the experiments with the CD73 deficient and adenosine
receptor deficient mice demonstrated that dephosphorylation of 5’-AMP to
adenosine and adenosine receptors signaling was not essential to induce the deep
hypometabolism model. Further biochemical analysis was needed to determine the
fate of the 5’-AMP. We undertook studies to determine the metabolic and
biochemical changes that occur after 5’-AMP injection.
The serum of mice in DH contains elevated purine catabolic products
A metabolomics study gave a detailed overview of the metabolic status of mice in
DH. Serum was analyzed from mice before injection, 3 hours into DH, at the arousal
stage, and early in their recovery. Analysis incorporated liquid and gas
chromatography and mass spectrometry to determine the metabolites in the
samples and calculate relative fold difference from the euthermic state, and was
carried out by a commercial service company (Metabolon, Research Triangle Park,
NC). Compared to the euthermic level, the 5’-AMP level in the serum of mice in
deep hypometabolism and at the arousal stage was increased only by 1.2 - 1.5 fold.
This suggests that much of the injected 5’-AMP had already been catabolized by
the time the mice were in DH. Further evidence of the 5’-AMP catabolism came
from the results that showed levels of several of the purine catabolites, such as
inosine, xanthine, xanthosine, hypoxanthine, urate, and allantoin had greatly
increased by DH (Table 1). Analysis of serum metabolites of mice in early recovery
showed that the purine catabolites had generally returned to the levels seen in mice
before injection, with the exception of allantoin, the final product in the purine
catabolic pathway in mice. During the deep hypometabolic state, there was about a
70

2 fold increase in ADP levels, whereas adenosine levels were lower than euthermic
state. The metabolite measurements suggest that the 5’-AMP is being primarily
catabolized by the AMP deaminase rather than through the adenosine deaminase
pathway (Table 1).
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Table 1 Metabolomics analysis shows significant alternation in relative levels of
purine intermediates in serum. This research was originally published in The
Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T,
Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the
American Society for Biochemistry and Molecular Biology.
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Serum and erythrocytes of mice in DH have elevated 2,3-bisphosphoglycerate
Another interesting finding from the metabolomics analysis is that there was
a large increase in 2,3-bisphosphoglycerate (2,3-BPG) in the mice in DH compared
to mice preinjection (Table 2). 2,3-BPG is synthesized from 1,3-BPG in the
erythrocyte and in the placenta, catalyzed by the enzyme bisphosphoglycerate
mutase. This enzyme is only found in erythrocytes and placenta, so the increase in
2,3-BPG during DH suggested that the erythrocyte is implicated in the model. To
further investigate the timing of the increase in 2,3-BPG after 5’-AMP injection, an
experiment was performed in which the 2,3-BPG levels were measured in
erythrocyte samples isolated from blood taken from mice over a time course before
and after 5’-AMP injection (Figure 16). The 2,3-BPG levels had significantly
increased by the first sampling 10 minutes after injection, and continued to rise
during the following 30 minutes. However, by arousal state, the levels of 2,3-BPG
had returned to preinjection levels. These results suggested the possibility that the
erythrocyte is involved in the underlying mechanism of deep hypometabolism
induced by 5’-AMP.
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Table 2: Metabolomics analysis shows 3.57-fold increase in 2,3-BPG in serum of
mice in DH compared to euthermia
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Figure 16: 2,3-BPG levels rise in the erythrocytes (RBC) of mice after 5’-AMP
injection and then return to pretreatment levels by arousal from DH. n = 6, error
bars indicate +/- S.E.M, p< 0.05. This research was originally published in The
Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T,
Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. © the
American Society for Biochemistry and Molecular Biology.
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After 14C-AMP injection in vivo, 14C signal is highest in blood, heart, lung and
kidney
A literature search revealed a study in which mice were injected with 11CAMP and then the 11C signal was traced to primarily lungs, blood and heart. The
authors did not perfuse the tissues, so some of the signals in lung and heart may
have come from blood in these organs (39). The authors observed that very little of
the 11C signal crossed the blood brain barrier. In the study, they further
demonstrated that the 11C-AMP was rapidly taken up by erythrocytes and was first
converted to ADP and then ATP. In addition, they showed that uptake of 11C-AMP
by the blood, unlike in the lungs, was not inhibited by dipyridamole, an inhibitor of
adenosine uptake by the cells. The authors also observed that kidney and bladder
were critical organs for the 11C signal, indicating that the 11C-AMP is metabolized
and cleared through the urinary system. To replicate these studies, blood and
perfused tissues were collected from a female C57Bl/6 mouse 5 minutes after
injection with 14C-AMP (Figure 17). Samples were homogenized and then
scintillation counts of 14C signal were measured, normalized to protein
concentration. Similar to the published results, the highest 14C signal was in the
blood, heart, and lung, and in addition the kidney had high counts. Consistent with
published observations, there was very little 14C signal in the brain, which suggests
that the injected 5’-AMP did not cross the blood-brain barrier. The observation that
blood had high 14C signal corresponded with the results showing elevated 2,3-BPG
levels in the mice given 5’-AMP, suggesting that the erythrocyte could be an
important target of the metabolite.
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Figure 17: 14C signal is highest in blood, heart, lung and kidney after 14C-AMP
injection in vivo. Blood and tissues were collected from a wild-type C57Bl/6 female
mouse 5 minutes post-injection with 14C-AMP.
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Glycolysis is slowed in the erythrocytes of mice in DH
The metabolite 2,3-BPG is a product of the glycolytic shunt in the
erythrocyte. The glycolytic shunt is favored when glycolysis is slowed (16, 40). A
slower rate of glycolysis would cause an increase in cellular glucose, and a
decrease in lactate. Therefore, we measured glucose and lactate levels in the
isolated erythrocytes of mice before 5’-AMP treatment and also during DH (Figure
18). The glucose levels of mice in DH were 3 times higher than pre-injection,
whereas the lactate levels were 2 times lower. These results are consistent with a
slowed glycolysis in the erythrocytes of the mice injected with 5’-AMP and this is
related to the increase in 2,3-BPG. Together, these studies implicate a role for the
erythrocytes in the 5’-AMP mediated hypometabolism.
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Figure 18: Glucose levels increase and lactate levels decrease in the erythrocytes
of mice treated with 5’-AMP. n = 4, error bars indicate +/- S.E.M, p< 0.01. This
research was originally published in The Journal of Biological Chemistry. Daniels IS,
Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol
Chem. 2010; 285:20716-20723. © the American Society for Biochemistry and
Molecular Biology.
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5’-AMP is taken up and metabolized in erythrocytes, favoring formation of
ADP
Erythrocytes are unique in that they lack nuclei and mitochondria, therefore
they rely primarily on glycolysis to make ATP and they are unable to perform de
novo nucleotide synthesis (41, 42). Mature erythrocytes lack the enzyme
adenylosuccinate synthetase, which catalyzes conversion of inosine
monophosphate (IMP) to adenylosuccinate. Therefore, they are unable to complete
the purine nucleotide cycle to convert IMP to AMP. They must use salvage
pathways to recycle nucleotides (14, 41). Previous experiments had shown that
extracellular adenosine is not required to initiate the model, but implicate that 5’AMP itself was entering the erythrocyte. Currently there is no described transporter
for 5’-AMP, but it has been reported that adenosine cyclic 3’,5’-monophosphate
(cAMP) and guanosine 3’,5’-cyclic monophosphate (cGMP) can enter erythrocytes
(43, 44). Adenosine can rapidly enter the erythrocyte (45). Previous studies have
demonstrated uptake of 14C-labeled adenosine into erythrocytes, and analyzed the
14

C-labeled products inside the erythrocyte lysate (45). Experiments were

performed to determine if 14C-AMP can directly enter the erythrocyte (Figure 19).
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Figure 19: Uptake of 14C labeled adenosine and 5’-AMP into erythrocytes isolated
from wild-type mice, compared with known 14C-labeled purine standards.
Erythrocyte lysates were separated by thin layer chromatography. This research
was originally published in The Journal of Biological Chemistry. Daniels IS, Zhang J,
O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem.
2010; 285:20716-20723. © the American Society for Biochemistry and Molecular
Biology.
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First, the experiment was performed with 14C-adenosine to determine if the
published results could be replicated. Isolated wild-type mouse erythrocytes were
incubated with 14C-adenosine over a time course up to one hour, and then washed
and lysed. The contents of the cell lysate were separated by thin layer
chromatography (TLC) and the radiolabeled contents were visible on an
autoradiogram of the TLC plate. Radiolabeled standards were run on the TLC plate
to identify the products. We observed that adenosine was taken up into the cells
rapidly, consistent with the published literature. The 14C-adenosine taken up into
the erythrocytes mainly formed 14C-AMP and 14C–ADP. This suggests that inside
the cell, adenosine is being phosphorylated by adenosine kinase to form AMP and
then phosphorylated by adenylate kinase into ADP. When the experiment was
performed with 14C-AMP, rapid uptake was also observed. Product formation
favored 14C-ADP, and there was no detectable formation of ATP. These
observations could be explained by the adenylate equilibrium AMP + ATP  2
ADP. If AMP levels rise inside the cell, the adenylate equilibrium will balance this
rise by converting part of the 5’-AMP into ADP by utilizing intracellular ATP. Similar
outcome was observed when erythrocytes from CD73 deficient mice were used.
Analysis of the lysate contents showed uptake of 14C-AMP, and formation of
ADP, with trace levels of inosine and adenosine. The presence of inosine and
adenosine suggests that the AMP inside the cell could be catabolized by AMP
deaminase to IMP, and then IMP could be dephosphorylated to inosine by cytosolic
nucleotidase. An alternative path could be AMP  adenosine by cytosolic
nucleotidase, and then adenosine  inosine by adenosine deaminase. Uptake by
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the CD73 deficient erythrocytes suggested the 14C-AMP is likely entering the cell
directly. In addition, previous studies showed that uptake of 5’-AMP by erythrocytes
is not blocked by dipyridamole, unlike in the peripheral tissues (39).
ADP rises, ATP declines, and 5’-AMP is metabolized in blood of mice in DH
It was evident that 5’-AMP is taken up into the erythrocyte in the in vitro 14CAMP uptake experiments. However, to determine the fate of the 5’-AMP in vivo, an
analysis of the purine nucleotides in blood was performed using HPLC. Blood
extracts were analyzed from mice in euthermia, deep hypometabolism, arousal
stage, and mice given a second injection of 5’-AMP during the deep hypometabolic
state (Figure 20).
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Figure 20: Representative HPLC chromatograms of purine products in wild-type
mouse blood extracts of mice in a) euthermia, b) during DH c) spontaneous arousal,
d) a mouse given a second injection of 5’-AMP (0.5 mg/gw) and sacrificed 2 hours
later. This research was originally published in The Journal of Biological Chemistry.
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC.
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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c) Spontaneous Arousal

The extract from the deep hypometabolic state had increased ADP and AMP, and
decreased ATP levels. This suggested influx of AMP caused a change in the
adenylate equilibrium, forcing an increase in the ADP which caused a decrease in
the ATP level. Also, there was evidence of metabolism of AMP as shown by the
appearance of inosine and uric acid, products of purine metabolism. The blood
extract from mice given a second injection of 5’-AMP after entering DH showed a
large increase in
ADP
level as well as the inosine and
uric acid.
Due
b) the
Deep
Hypometabolism
d) 5’-AMP
during
DH to the
adenylate equilibrium, AMP + ATP  2 ADP, the ATP level decreased
dramatically. This suggests that there was more metabolism of the 5’-AMP, shifting
the adenylate equilibrium to very low ATP levels. This result corresponds with the
observation that a second injection of 5’-AMP while the animal is already in DH is

Erythrocytes of mice given 5’-AMP have increased levels of deoxyhemoglobin
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Experiments had shown that the erythrocytes of mice in DH had elevated
2,3-BPG, which is known as an allosteric regulator of the ability of hemoglobin to
bind oxygen (14). Thus, high levels of 2,3-BPG would cause less oxygen to be
bound to hemoglobin. When analyzed by a spectrophotometer, deoxyhemoglobin
has signature peak absorbance at 760 nm, whereas oxyhemoglobin has weaker
absorbance at 660 nm. Blood samples were taken 10 minutes post-injection of 0.5
mg/gw 5’-AMP or saline. Spectral analysis of samples from the treated mice
showed evidence of deoxyhemoglobin at 760 nm. In contrast, samples from the
untreated group had weaker absorbance at 660 nm, showing presence of more
oxyhemoglobin (Figure 21). The results confirm that erythrocytes of mice treated
with 5’-AMP are less able to transport oxygen to tissues.
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Figure 21: Spectral absorbance of whole blood from mice treated with 5’-AMP
(dashed lines) or untreated (solid lines). Blood samples were taken 10 minutes after
5’-AMP injection, i.p., (0.5 mg/gw), n = 2. This research was originally published in
The Journal of Biological Chemistry. Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki
T, Zhao Z, Blackburn MR, Lee CC. Title. J Biol Chem. 2010; 285:20716-20723. ©
the American Society for Biochemistry and Molecular Biology.
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Summary of results
The metabolomics study showed an increase in 2,3-BPG in the serum of
mice in DH. Erythrocytes isolated from mice treated with 5’-AMP also had increased
2,3-BPG levels, as well as increased glucose and decreased lactate levels,
indicating slower rate of glycolysis. Hemoglobin oxygen affinity is inhibited by 2,3BPG, and spectrophotometry analysis demonstrated that the injection of 5’-AMP
resulted in increased levels of deoxyhemoglobin levels. Consistent with previous
studies, our tracing of 14C signal in tissues after injection of radiolabeled 5’-AMP
demonstrated highest localization in blood and in vascular tissues such as heart,
lung and kidney. Furthermore, in vitro treatment of isolated erythrocytes with 14CAMP showed evidence of direct uptake and metabolism of 5’-AMP. HPLC analysis
of the purine products in blood extracts of mice in DH demonstrated that
metabolism of 5’-AMP occurs in the blood, and there is a shift in the adenylate
equilibrium favoring formation of ADP and decrease in ATP levels. Taken together,
these results indicate uptake of 5’-AMP into the erythrocyte is involved in the
initiation of the DH state.
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Chapter 6
AMP Deaminase in the erythrocyte plays an
important role in control of the DH model
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AMP deaminase is the major pathway for 5’-AMP catabolism inside the cell.
AMP deaminase catalyzes deamination of 5’-AMP to 5’-inosine monophosphate (5’IMP), requiring a H2O molecule and releasing NH4+ (14) (Figure 22). IMP can be
converted to inosine via cytosolic nucleotidase. Inosine then is converted to
hypoxanthine, then xanthine, and then urate. The final product in humans is urate
but many species including mice have urate oxidase which creates the final product
allantoin (16).
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Figure 22: Adenine nucleotide metabolism pathways inside and outside the
cell
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Humans have four isozymes of AMPD that are encoded on different genes.
AMPD1, also called myodenylate deaminase, is the main type in skeletal muscle.
AMPD2, also called L form, was first isolated from liver, and AMPD3, also called E
form, is highly expressed in heart tissue. In humans and other species, many
tissues express multiple AMPD isozymes in varying amounts. AMPD3 as well as
other AMPD isozymes are expressed in heart and slow-twitch skeletal muscle, but
interestingly, erythrocytes only have AMPD3 (46, 47). In humans, AMPD3 has two
splice variants: E1 and E2, and the E1 variant is the only type found in erythrocytes.
AMPD3 E2 type is found in granulocytes, AMPD2 is found in mononuclear cells,
platelets and T-cells, whereas both AMPD3 E1 and AMPD2 are found in B-cells
(48-50).
In the literature there are a few described cases of genetic mutation causing
a complete lack of AMPD3 in humans. The deficiency was found to be clinically
asymptomatic, although there is an increase of steady-state ATP levels to 150% in
the affected cells (51). Unlike human AMPD3, murine AMPD3 just has one form; it
has no splice variants. It is also called heart AMPD3, because the cDNA was first
isolated and cloned from mouse heart, where it is highly expressed (47).
In most mammalian species, erythrocytes lack an enzyme that allows IMP to
be converted to 5’-AMP. The conversion of 5’-AMP to IMP is irreversible because
the cells lack the enzyme adenylosuccinyl synthetase and thus lack the ability to
convert IMP back to AMP (41, 42).
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Studying mice deficient in AMPD3 in the erythrocyte could help elucidate the
role of AMPD and the erythrocyte in the DH model. Thus, we undertook the
generation of mice deficient in AMPD3. Embryonic stem cells with C57Bl/6
background were purchased from Knockout Mouse Project Repository, University of
California, Davis, CA. The vector used the “knockout-first” technology to insert the
cassette in the intron 1 before the essential exon 2 to create a missense mutation
that results in a non-functional mRNA transcript. The cells were injected into the
blastocysts of pseudopregnant C57Bl/6 females at the core facility at Institute for
Molecular Medicine, Houston, TX, and chimeras were generated. Chimeras were
mated with C57Bl/6 mice to generate heterozygous knockouts, and then
homozygous knockouts were generated.

AMPD activity is not detectable in erythrocytes and is reduced in heart of
AMPD3 deficient mice
To confirm that the gene knockout was successful, it was necessary to
measure the AMPD enzyme activity in the tissues of the mice, including the
erythrocytes (Figure 23).
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Figure 23: AMPD activity is not detectable in the erythrocytes (rbc) and is reduced
in the heart of AMPD3 deficient mice. erythrocytes (rbc) n = 15 wild-type and n = 7
AMPD3 deficient. serum n = 10 wild-type and n = 5 AMPD3 deficient. heart n = 8
wild-type and 8 AMPD3 deficient. All other tissues n = 3. Error bars = +/- S.E.M
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AMPD activity was measured by quantifying the IMP formed in a reaction of
tissue lysate using 5’-AMP as previously described (52). In parallel, wild-type mouse
tissues were measured as controls. In most tissues, AMPD3 deficient mice had
AMPD activity comparable to wild-type. However, there was much lower AMPD
activity in heart, as compared to wild-type, and the AMPD activity in the erythrocyte
lysate was not detectable. Other isozymes of AMPD are expressed in the heart, so
it would be expected to have some AMPD activity. The erythrocyte lysate of
heterozygous mice had less AMPD activity than wild-type, but more than the
deficient mice (Figure 24). The results demonstrate that the AMPD3 enzyme is not
active in the AMPD3 deficient mice.
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Figure 24: AMPD activity in erythrocyte lysate of wild-type, heterozygous and
homozygous AMPD3 deficient mice. n = 2-3 mice per group, error bars = +/= S.E.M
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ATP and ADP but not 5’-AMP levels are elevated in the erythrocytes of AMPD3
deficient mice
Next, we investigated whether the loss of AMPD3 will result in elevated
levels of 5’-AMP in the erythrocyte of AMPD3 deficient mice. HPLC analysis was
performed to quantify the levels of ATP, ADP and 5’-AMP in methanol extracts of
erythrocyte lysate (Figure 25).
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Figure 25: Erythrocyte lysates of AMPD3 deficient mice have 3-fold higher ATP and
ADP levels and similar AMP levels to wild-type mice. Nucleotides from methanol
extracts of erythrocyte lysates were separated on HPLC and quantified by
calibration curves of standards. n = 4, error bars = +/- S.E.M. Student t-test p
values: ATP, p = 0.02. ADP, p = 0.04.
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Adenine nucleotide amounts were quantified against calibration curves for
ATP, ADP and 5’-AMP, and normalized to the protein concentration in each lysate
sample. While the AMP levels were similar to wild-type, AMPD3 deficient
erythrocytes had a 3-fold increase in both ATP and ADP levels. These results are
contrary to our prediction but are consistent with observation in humans deficient in
AMPD3. The affected cells in humans with AMPD3 deficiency have 150% of normal
ATP levels, although ADP and 5’-AMP levels are not mentioned (53). A possible
explanation for the observation is that the loss of AMPD3 blocks the breakdown of
5’-AMP to IMP. The only catabolic exit for 5’-AMP is via adenosine to inosine by
adenosine deaminase (ADA). However, the Km of ADA is much higher than that of
adenosine kinase, which converts adenosine to AMP. Consequently, the adenine
nucleotide pool is much larger, and to balance the adenylate equilibrium, both ATP
and ADP have to rise, consequently 5’-AMP levels remain low.
AMPD3 deficient mice have similar metabolic rate and glucose utilization to
wild-type mice
We then investigated whether the change in the adenylate levels in the
erythrocyte will affect metabolic rate of the animals. The calculation for VO2,
mg/kg/h, involves the weight of the animal. We have consistently observed that a
lower weight animal tends to have a higher metabolic rate. To overcome this
possible artifact, we chose similar weight mice to compare VO2 between animals.
Wild-type, heterozygous and homozygous AMPD3 deficient male mice of similar
weight were measured in the CLAMS metabolic chamber for 7 days with free
access to food and water, and under 22°C Ta. Our analysis revealed that there was
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no significant difference in VO2 for the different genotypes. Average VO2 of wildtypes was 3530 ml/kg/hr, heterozygous mice was 3412 ml/kg/hr and homozygous
mice was 3473 ml/kg/hr (Figure 26).

111

Figure 26: Metabolic rates (VO2) are similar in similar weight male wild-type,
heterozygous and homozygous AMPD3 deficient mice. wild-type n = 5,
heterozygous n = 4, homozygous n = 7. Error bars = +/- S.E.M.
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It is well known that ATP/AMP ratio acts as allosteric regulator for key
enzymes of glycolysis. Elevated AMP levels signal a need for ATP production, and
activate phosphofructokinase 1, a key enzyme in the glycolytic pathway (16).
Potentially the change in adenine nucleotide ratio could affect glycolytic rate and
therefore blood glucose levels. Thus, we undertook to measure fasting blood
glucose in wild-type and AMPD3 deficient mice (Figure 27).
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Figure 27: AMPD3 deficient mice have similar fasting blood glucose to wild-type
and heterozygous mice. wild-type n = 14, heterozygous n = 9, homozygous n = 16.
Error bars = +/- S.E.M.
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Animals were fasted overnight for 12 hours and then blood glucose was
measured the next morning. In a parallel experiment animals were fasted for 12
hours during the day and blood glucose was measured at night. In both
experiments, the AMPD3 deficient mice had slightly higher glucose levels, but it was
not statistically significant and is within the normal range of fasting blood glucose.
The average fasting blood glucose of the wild-type mice was 69 mg/dl,
heterozygous mice was 70 mg/dl, and homozygous mice was 73 mg/dl. These
studies indicate that glucose utilization was within normal range in AMPD3 deficient
mice.
AMPD3 deficient mice have more dramatic response to injection of 5’-AMP
Next we investigated how AMPD3 deficient mice would respond to injection
of exogenous 5’-AMP. We predicted that 5’-AMP would be catabolized more slowly
in the erythrocytes lacking AMPD3 and they would be more sensitive to 5’-AMP induced DH. Wild-type and AMPD3 deficient mice were injected with a dose of 5’AMP and then placed in a 15°C metabolic chamber with free access to food and
water. They were monitored and VO2 was recorded until all the animals recovered
from DH. First, a series of dose titration experiments were performed to determine
the minimum 5’-AMP dose at which wild-type and AMPD3 deficient mice responded
differently. That dose was 0.15 mg/gw 5’-AMP when using 15°C Ta. All the animals
experienced the immediate Phase I response after the 5’-AMP injection. The data
was analyzed based on length of time in the Phase II response. Since Tb decreases
when the VO2 drops below 1500 ml/kg/h, the average time in Phase II state was
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used to determine the Phase II response. On average, the AMPD3 deficient mice
stayed in the Phase II response much longer than the wild-type mice (Figure 28).
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Figure 28: Male and female AMPD3 deficient mice stay in Phase II response much
longer than wild-type mice when injected with a lower dose of 5’-AMP (0.15 mg/gw)
and maintained in 15°C Ta. Time in Phase II response is represented as minutes
the VO2 is below 1500 ml/kg/h. females n = 12 each group, males n = 3. Error bars
= +/- S.E.M.
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The AMPD3 deficient females stayed in Phase II 81 minutes, compared to
wild-type females with an average of 21 minutes. Similarly the AMPD3 deficient
males stayed in Phase II for 216 minutes, compared to wild-type male mice which
stayed in Phase II for 42 minutes. Thus, the AMPD3 deficient mice stay in Phase II
much longer than the wild-type animals, indicating that they were more sensitive to
a lower dose of 5’-AMP.
AMPD3 deficient mice have lower core body temperature than wild-type mice
Next, we examined whether the core body temperature of wild-type and
AMPD3 deficient mice was normal. Since physical activity or stress can directly
impact Tb, we decided to use the telemetry approach for this measurement.
Telemetry-chip implanted animals were placed in a 22°C metabolic chamber with
free access to food and water, and core body temperature was measured over a
period of 7 days (Figure 29).
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Figure 29: AMPD3 deficient mice have lower Tb than wild-type mice. Tb of
telemetry-implanted mice was measured for 7 days in a 22°C Ta. Error bars = +/S.E.M., n= 7 each group.
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To analyze the data, the average of the highest and lowest ten percent
recordings was calculated. The average top ten percent readings for the AMPD3
deficient mice was 37.0°C, almost a full degree lower than the wild type mice
average of 37.8°C. The average bottom ten percent readings for the AMPD3
deficient mice was 32.5°C, almost 2 degrees lower than the wild type mice average
of 34.3°C. It is evident from the graph of the Tb of the wild-type and AMPD3
deficient mice that both genotypes have the normal fluctuations in body temperature
throughout the day that correspond to rest and activity. However, in the AMPD3
deficient mice the high and low body temperatures are shifted lower in comparison
to wild-type.
AMPD3 deficient mice have difficulty maintaining normal body temperature
under moderate metabolic stress
To further explore the AMPD3 deficient mouse phenotype of lower core body
temperature, it was important to determine how the animals would react to
metabolic stress such as a slight decrease in ambient temperature. Wild-type and
AMPD3 deficient mice were placed in the metabolic chamber at 22°C, with free
access to food and water for 5 days. Then the ambient temperature in the chamber
was decreased to 18°C, and the animals were monitored for two more days. Both
groups of mice showed an increase in VO2 when the ambient temperature
decreased. The wild-type mice maintained their Tb, that accompanied the increase
in VO 2. However, some AMPD3 deficient mice had a decline in Tb after the ambient
temperature decreased, even though their VO2 had increased (Figure 30). Also, in a
few of the mice, it was observed that some AMPD3 deficient mice would
124

spontaneously enter daily torpor even during the 22°C period (Figure 31). These
observations indicate the AMPD3 deficient mice are impaired in their ability to
maintain core body temperature. It is important to note that under extreme
metabolic stress such as fasting or Ta of 15°C or lower, both wild-type and AMPD3
deficient mice will undergo torpor.
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Figure 30: Some AMPD3 deficient mice have reduced ability to maintain Tb when
Ta is reduced from 22°C to 18°C, despite increase in VO2. Representative plot of
VO2 and Tb from one wild-type and one AMPD3 deficient mouse. Note that random
outliers in Tb measurement are caused by the positioning of the mouse and
telemetry chip to the sensor.
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Figure 31: Daily torpor of AMPD3 deficient mice at 22°C Ta. Representative plot of
VO2 and Tb of an AMPD3 deficent mouse entering torpor in 22°C and 18°C Ta, over
a period of 6 days with free access to food and water. Note that random outliers in
Tb measurement are caused by the positioning of the mouse and telemetry chip to
the sensor.
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Summary of Results
In summary, AMPD3 deficient mice have similar VO2 and glucose utilization
to wild-type mice. They display a more dramatic response to lower dose 5’-AMP
injection than wild-type mice, suggesting that AMPD3 activity, specifically in the
erythrocyte, is important to the control of the 5’-AMP – induced model of DH. The
increased ATP and ADP in the erythrocytes, their lower Tb phenotype, and the
difficulty some of the mice have maintaining Tb during moderate metabolic stress
suggest altered energy homeostasis that must be further investigated.
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Chapter 7
Discussion and Future Directions
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Expression level of most genes in mouse liver are unaltered during DH
The physiological effects of the 5’-AMP injection occur so rapidly
(immediately) that the laboratory’s initial studies on the mechanism focused on
biochemical changes rather than gene expression. However, it was important to
determine what changes in gene expression occur after 5’-AMP treatment. A
microarray study compared the expression of genes in the liver, a highly metabolic
organ, of mice in DH, at arousal, and recovered from DH, compared to control
untreated mice. More than 99% of gene expression in the liver was unchanged in
DH, compared to untreated animals. In contrast, the arousal stage had much more
change in gene expression, with about 200 genes differentially expressed
compared to only about 40 genes in the DH state. These results showed that
patterns of gene expression are mostly held constant during DH. The expression of
circadian genes is stalled as well. Analysis of expression 24 and 48 hours post
recovery indicated that the circadian clock takes approximately 24 hours to reset
after DH. The cold Tb likely causes the stalling of most gene expression changes in
DH (54).
Model for initiation of 5’-AMP - induced deep hypometabolism
Adenosine receptor signaling is known to be involved in thermoregulation
and heart rate, both of which undergo dramatic changes in the DH model (37).
Since 5’-AMP can be dephosphorylated to adenosine, the initial focus on
determining the fate of the injected 5’-AMP was to assess the role of adenosine in
initiating DH. Experiments with mice lacking the enzyme 5’-ectonucleotidase/CD73
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or the adenosine receptors demonstrated the animals were able to enter DH
similarly to wild-type mice. Results from these independent genetic approaches
indicated that the dephosphorylation of 5’-AMP to adenosine outside the cell is not
required to initiate the DH model.
Next, the focus turned to identifying whether 5’-AMP was the molecule that
initiates DH. Experiments showed that mice injected with 5’-CMP and 5’-GMP did
not experience a decline in metabolic rate. It was found that adenosine, ATP and
ADP do induce a decline in VO2 but it is more transitory and had slower kinetics
than in mice given 5’-AMP. This can be explained because the adenine nucleotides
are being modified into 5’-AMP in vivo. In contrast adenosine had similar kinetics to
5’-AMP but the effect on VO2 is very transient. In addition, adenosine has low
solubility in water and it has a very short half-life of less than 10 seconds in serum.
(36). These factors likely account for the reason mice injected with adenosine did
not enter DH, as it is rapidly degraded before DH could take hold. It is possible that
given a continuous transfusion, adenosine could induce DH. In comparison with
mice injected with 5’-AMP, the VO2 declined less rapidly in mice given cAMP, and
ATP. Other investigators have observed similar results with ADP and ATP given at
similar concentration. Together, these results indicate that 5’-AMP itself is
responsible for initiating the DH state.
Analysis of 14C signal in perfused tissues after injection of 14C-AMP in a
mouse confirmed what had already been found in published data (39). The
radiolabel is most concentrated in the blood and in vascular organs such as heart,
lung and kidney, and does not concentrate in the brain. In addition, the Mathews
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group had found that 5’-[11C]-AMP uptake in blood changed the ADP/ATP ratio,
which would occur by the adenylate equilibrium, AMP + ATP  2ADP (39). In
vitro 14C-AMP uptake experiments in erythrocytes isolated from wild-type and CD73
deficient mice and visualized with thin layer chromatography showed that 5’-AMP is
taken up in the cells and metabolism favors formation of ADP, which corresponds to
the adenylate equilibrium. This information, along with HPLC analysis of blood
extracts from mice given 5’-AMP indicated that the 5’-AMP is taken up in the
erythrocytes and forces the adenylate equilibrium to increase ADP production, thus
reducing ATP levels. Evidence from the metabolomics study and other metabolic
analysis of mice treated with 5’-AMP suggested that glycolysis is slowed in mice in
DH. Glucose is elevated and lactate is decreased. These data taken together led to
the hypothesized model for the initiation step of the DH model (Figure 32).
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Figure 32: Proposed model for initiation of 5’-AMP – induced deep hypometabolism
This research was originally published in The Journal of Biological Chemistry.
Daniels IS, Zhang J, O’Brien WG, Tao Z, Miki T, Zhao Z, Blackburn MR, Lee CC.
Title. J Biol Chem. 2010; 285:20716-20723. © the American Society for
Biochemistry and Molecular Biology.
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The first step of the glycolytic pathway requires ATP for conversion of
glucose to glucose-6-phosphate, catalyzed by hexokinase (14). If intracellular ATP
levels decrease, then glycolysis would slow and glucose would build up and less
lactate, the end product, would be formed. Previous investigators have performed
metabolic modeling that indicates when glycolysis slows an increase in 2,3-BPG
production occurs in order to stabilize the ATP levels in erythrocytes. Therefore, a
small variation in the intracellular ATP level could cause a great increase in 2,3BPG production in the erythrocyte (40).
2,3-BPG is known to allosterically regulate hemoglobin’s affinity for oxygen
(16). It binds strongly to deoxyhemoglobin, but binds weakly to oxyhemoglobin (14,
40). Therefore, increased 2,3-BPG in the erythrocytes of an animal injected with 5’AMP would cause less oxygen transport to tissues. Evidence of this is seen in the
physiological observations and measurements of animals injected with 5’-AMP. The
Phase I response, in which VO2 rapidly and dramatically decreases, may be a
reflection of the sudden reduction in oxygen transport to tissues. Also, the allosteric
nature of 2,3-BPG regulation of hemoglobin affinity for oxygen could be the reason
that a range of doses of 5’-AMP all trigger a Phase I response of similar magnitude.
The elevated 2,3-BPG levels are further confirmed by the spectral analysis of blood
taken 10 minutes after 5’-AMP injection showing increased deoxyhemoglobin and
decreased oxyhemoglobin levels. The reduced oxygen transport to the tissues
could trigger a whole body physiological response to lower metabolic rate. If this
occurs in a cooler environment, then the body will lose heat and be unable to
maintain euthermic Tb due to the lower metabolic rate. Tb will continue to decrease
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toward the Ta. During the Phase II response, in which Tb gradually decreases as
VO2 continues to decline, the body would not require as much oxygen, which in turn
allows the VO2 to drop further. As demonstrated by experiments measuring time to
recovery from DH in different Ta, the correct Ta will allow the animal to maintain the
DH state, and the animal’s Tb and the Ta will be in equilibrium. If the animal in DH is
gradually rewarmed, the VO2 will increase, causing arousal from DH. However,
there is much variation in the how long mice maintained in the same Ta remain in
DH, which suggests there are still factors to be determined that control the length of
time in DH.
Discussion of erythrocyte as initiation site for 5’-AMP – induced deep
hypometabolism
Metabolic rate in small mammals can be pharmacologically reduced by
treatment with 2-deoxyglucose or hydrogen sulfide gas (H2S) (22, 55). While it is not
understood how these metabolic inhibitors reduce Tb, the effects on erythrocytes
are known. Erythrocytes metabolize inhaled H2S gas in the following reaction: HbO2
+ H2S  2S + Hb + H2O, and oxygen levels are greatly decreased (23). In the case
of 2-deoxyglucose, a known inhibitor of hexokinase, the first step in glycolysis is
stopped. Since erythrocytes rely primarily on glycolysis to produce ATP, the cellular
level of ATP would decrease. The role of the erythrocyte in 2-deoxyglucose
induction of torpor is further suggested because a different metabolic inhibitor, βmercaptoacetate, does not induce torpor in small mammals. β-mercaptoacetate
inhibits β-oxidation, a function of mitochondria. Erythrocytes lack mitochondria (14,
55). Further evidence of the role of the erythrocyte is that previous investigators
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have used exsanguination to reduce Tb in mammals (56, 57). Also, hypoxia is
known to cause hypothermia (58). In summary, the results suggest the erythrocyte
may be the site for the initiation of many different methods of reducing metabolic
rate in mammals.
Discussion of AMPD3 deficient mice phenotype and AMPD3 role in 5’-AMPinduced model of deep hypometabolism
The determination that the erythrocyte is the site of initiation of the DH model
led to studies to determine whether AMP deaminase, specifically in the erythrocyte,
plays a role in the control of the DH model. AMPD3 deficient mice had undetectable
AMPD activity in erythrocytes, and reduced activity in heart tissue as evident from
the lack of IMP formation in the erythrocyte lysates.
AMPD3 deficient mice remaining in Phase II response longer than wild-type
mice after lower dosage of 5’-AMP indicates that the AMPD catabolism of 5’-AMP,
specifically in the erythrocyte, is important in the 5’-AMP – induced DH model.
Future investigations will test whether AMPD3/CD73 deficient mice injected with
lower dose 5’- AMP have an even more dramatic response than the AMPD3
deficient mice. Lack of 5’-AMP catabolism outside the cell by CD73, combined with
a lack of 5’-AMP catabolism inside the cell by AMPD3 could possibly cause a low
5’-AMP dose to be effectively higher in these mice.
We observed that the VO2 was similar in wild-type, heterozygous and
homozygous AMPD3 deficient mice. A similar glucose level in fasting blood glucose
experiments also suggested the AMPD3 deficient mice have similar metabolic
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phenotype to wild-type, at least under normal metabolic state. However, analysis of
the Tb of telemetry implanted AMPD3 deficient mice showed a lower Tb in constant
22°C Ta, and some have difficulty maintaining Tb under moderate metabolic stress.
Observation of the lower Tb phenotype led to the question of how the Tb
could be reduced without such apparent decrease in metabolic rate. Classically, Tb
regulation is controlled by the hypothalamus. The AMPD3 deficient mice are lacking
the AMPD activity only in the erythrocyte, so the hypothalamic thermoregulation
may not be directly affected by this genetic mutation. Rather, we speculate that
when under metabolic stress, delivery of oxygen to the tissue is important for
maintaining Tb. If the function of the erythrocyte is somehow impaired, the delivery
of oxygen to tissues may be inadequate. Hypoxia is known to decrease
thermogenesis (59). Investigators have found that brown adipose tissue of rats
maintained in hypoxic conditions since birth had greatly reduced uncoupling protein
content (59). Also, studies in CD-1 mice demonstrated that chronic hypoxia reduces
capacity for non-shivering thermogenesis and decreases the relative contents of
uncoupling protein 1 in brown adipose tissue and uncoupling protein 3 in
gastrocnemius muscle (15). Interestingly, chronically hypoxic CD-1 mice had a
decline in Tb to 35°C when placed in a 4°C Ta, although their VO2 increased similarly
to that of normoxic control mice. In contrast, the normoxic control mice maintained
euthermic Tb of 37°C in this acute metabolic stress condition (15). These findings
correspond to our observations in AMPD3 deficient mice. When Ta was reduced
from 22°C to 18°C, some AMPD3 deficient mice displayed inability to maintain Tb
despite a similar increase in VO2 to wild-type mice. Further studies will investigate
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the possibility that AMPD3 deficiency in mice impairs erythrocyte function, causing
mild chronic hypoxia, and consequently undermining non-shivering thermogenesis
capacity. Analysis of the brown adipose tissue and muscle uncoupling protein
content, and oxygenation status in the erythrocyte and tissues will give insight into
this question.
Possible explanations for increased ATP and ADP in erythrocytes of AMPD3
deficient mice
Analysis of the ATP, ADP and 5’-AMP levels in the erythrocyte lysate
extracts of the AMPD3 deficient mice showed that ATP and ADP are increased 3fold. This corresponds with published data describing 150% of normal level of ATP
in affected cells of humans with AMPD3 deficiency (51). In addition, analysis of
aged erythrocytes from rabbits demonstrate that erythrocyte AMP deaminase
activity reaches a minimum after 40 days in the 120 day erythrocyte lifespan. The
aged erythrocytes have elevated levels of ATP (60).
It has not been explained in the literature how ATP levels can rise when
erythrocytes lack AMPD3 to deaminate 5’-AMP to IMP. Cytosolic nucleotidase
dephosphorylates 5’-AMP to adenosine, but adenosine kinase which
phosphorylates adenosine back to 5’-AMP has a much lower Km than adenosine
deaminase, so phosphorylation of adenosine to 5’-AMP is favored. Thus, if
catabolism of 5’-AMP to IMP is blocked, then the adenine nucleotide pool would be
increased. By the adenylate equilibrium AMP + ATP  2 ADP, if 5’-AMP levels
rise, then to balance the equilibrium, ADP would have to increase and ATP should

141

decrease. Alternatively, the rise in ADP could be balanced by a rise in ATP and a
decline in 5’-AMP, which is what was observed.
Cytosolic nucleotidase can dephosphorylate AMP to adenosine, but then in
the next step adenosine kinase has a much lower Km than adenosine deaminase,
so phosphorylation of adenosine to AMP is favored (Figure 33) (14, 16, 60).
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Figure 33: Km values for metabolism of adenine nucleotides and nucleosides inside
the cell
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AMP formation would be favored until the substrate level was high enough to
overcome the lower Km of adenosine kinase, and allow adenosine deaminase to
convert some of the adenosine to inosine. This would cause a build-up of AMP,
which can be phosphorylated to ADP and ATP.
Possible role of Na+/K+ pump
Physiological concentration of 5’-AMP is much lower than ATP and ADP. In
erythrocytes, 5’-AMP concentration is about 14 µM, compared to 1,797 µM for ATP
and 227 µM for ADP (61). Maintaining the relative concentrations of ATP, ADP and
5’-AMP inside the cell is essential.
One possible reason for the adenine nucleotide pool in AMPD3 deficient
erythrocytes to be maintained in ATP/ADP rather than 5’-AMP/ADP is the
physiological need of the erythrocytes. The observed increase in ATP and ADP
levels in the erythrocyte lysate are within the normal ADP/ATP ratio. Maintenance of
this ratio would promote proper function of the Na+/K+ pump. The Na+/K+ pump, also
called the Na+/K+– ATPase, uses active transport to export Na+ and import K+, using
the energy from dephosphorylation of ATP to ADP (62). One of its functions is to
maintain the osmotic pressure within the cell, which is necessary to maintain cell
shape. Previous studies have investigated the effect of changing the ADP/ATP ratio
on the activity of the Na+/K+ pump in resealed erythrocyte ghosts. The investigators
used phosphoarginine or phosphocreatine-based systems to enzymatically
regenerate ADP or ATP to vary ADP/ATP ratios. Using an adenylate kinase
inhibitor, they prevented the adenylate equilibrium from re-equilibrating the AMP,
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ADP and ATP to normal ratios. Changes in ADP/ATP ratio affected the rate of ion
exchange (63). This could have significant impact on the homeostasis of intact
erythrocytes.
The energy homeostasis in erythrocytes of AMPD3 deficient mice may be
altered due to increased adenine nucleotide pools. This could cause an inability of
the erythrocytes to properly transport oxygen to tissues, which may result in the
decreased Tb phenotype. Further analysis is needed to understand this phenotype.
Conclusion
In summary, this dissertation describes a novel method for inducing a deep
hypometabolic state in mammals, induced by uptake and metabolism of a natural
molecule, 5’-AMP. Biochemical analyses and genetic approaches have provided
clues into the initiation and control of the model. This work adds to understanding of
the mechanisms involved in the 5’-AMP induced model of deep hypometabolism.
Possible future clinical application of the model in humans will require a deeper
comprehension of the mechanisms underlying this model.
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